AAAAAA
Results:
1-8
|
Results: 8
Authors:
Maclaren, N
Chen, QY
Kukreja, A
Marker, J
Zhang, CH
Sun, ZS
Citation: N. Maclaren et al., Autoimmune hypogonadism as part of an autoimmune polyglandular syndrome, J SOC GYN I, 8(1), 2001, pp. S52-S54
Authors:
Rapaport, R
Nuzzo, J
Schatz, D
Maclaren, N
Citation: R. Rapaport et al., Intervention to delay the onset of diabetes mellitus in very young siblings of children with type 1 diabetes mellitus, J PED END M, 14, 2001, pp. 623-626
Authors:
Marker, J
Maclaren, N
Citation: J. Marker et N. Maclaren, Immunopathology of immune-mediated (type 1) diabetes, CLIN LAB M, 21(1), 2001, pp. 15
Authors:
Ten, S
New, M
Maclaren, N
Citation: S. Ten et al., Addison's disease 2001, J CLIN END, 86(7), 2001, pp. 2909-2922
Authors:
Yu, LP
Cuthbertson, DD
Maclaren, N
Jackson, R
Palmer, JP
Orban, T
Eisenbarth, GS
Krischer, JP
Citation: Lp. Yu et al., Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial Type 1, DIABETES, 50(8), 2001, pp. 1735-1740
Authors:
Maclaren, N
Citation: N. Maclaren, Immunotherapy of immune-mediated diabetes - Present and future, CL R ALL IM, 19(3), 2000, pp. 277-297
Authors:
Heino, M
Scott, HS
Chen, QY
Peterson, P
Maenpaa, U
Papasavvas, MP
Mittaz, L
Barras, C
Rossier, C
Chrousos, GP
Stratakis, CA
Nagamine, K
Kudoh, J
Shimizu, N
Maclaren, N
Antonarakis, SE
Krohn, K
Citation: M. Heino et al., Mutation analyses of North American APS-1 patients, HUM MUTAT, 13(1), 1999, pp. 69-74
Authors:
Maclaren, N
Lan, M
Coutant, R
Schatz, D
Silverstein, J
Muir, A
Clare-Salzer, M
She, JX
Malone, J
Crockett, S
Schwartz, S
Quattrin, T
DeSilva, M
Vander Vegt, P
Notkins, A
Krischer, J
Citation: N. Maclaren et al., Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2 beta predict immune-mediated (type 1) diabetes in relatives, J AUTOIMMUN, 12(4), 1999, pp. 279-287
Risultati:
1-8
|